Status:
UNKNOWN
Appropriateness of Methodist Health System(MHS) Inter-facility Transfers of Traumatic Intracranial Subarachnoid Hemorrhage and Spontaneous Bleeds for Level-1 Advanced Surgical Intervention
Lead Sponsor:
Methodist Health System
Conditions:
Traumatic Intracranial Subarachnoid Hemorrhage
Eligibility:
All Genders
18-75 years
Brief Summary
Brain injuries are common and challenging problems faced by emergency physicians. These diagnoses may include traumatic intracerebral hemorrhage, subarachnoid hemorrhage, ruptured cerebral aneurysms, ...
Detailed Description
Brain injuries are common and challenging problems faced by emergency physicians. These diagnoses may include traumatic intracerebral hemorrhage, subarachnoid hemorrhage, ruptured cerebral aneurysms, ...
Eligibility Criteria
Inclusion
- Patients ≥18 years old
- Diagnosed with traumatic intracranial subarachnoid hemorrhage or a spontaneous bleed
- Patients originating at Methodist Mansfield medical center (MMMC) or Methodist Charlton medical center(MCMC)and subsequently transferred to Methodist Dallas medical center (MDMC)
Exclusion
- Does not meet inclusion criteria defined in section 3.1
Key Trial Info
Start Date :
June 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 20 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06136078
Start Date
June 20 2022
End Date
June 20 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Institute at Methodist Health System
Dallas, Texas, United States, 75203